Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Open in API
Filings indexed 1,645 across all filing types
Latest filing 2025-08-06 Capital/Financing Update
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
Please find attached the monitoring agency report for the quarter ended June 30, 2025
Capital/Financing Update Classification · 95% confidence The document is titled 'Monitoring Agency Report for the quarter ended 30th June 2025' and is issued pursuant to SEBI regulations related to the monitoring of proceeds from a Qualified Institutions Placement (QIP). It is a detailed report by CARE Ratings Limited, the appointed Monitoring Agency, covering the utilization of funds raised through the QIP. The report includes financial details, certifications, and comments on the use of proceeds, consistent with regulatory requirements for monitoring capital raised. The document is about the monitoring of capital utilization and compliance with issue objectives, which aligns with a Capital/Financing Update. It is not an annual or quarterly financial report, audit report, or earnings release, nor is it a simple announcement or certification. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (15,000 characters) and detailed content confirm it is the report itself, not just an announcement.
2025-08-06 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is titled 'Investor Presentation – Q1’ FY26' and is addressed to stock exchanges, indicating it is a formal communication to investors. The content includes detailed business and financial highlights for the quarter ended June 30, 2025, such as sales figures, market leadership, and segment performance. The document is about 15,000 characters long, which is consistent with a detailed presentation rather than a brief announcement. There is no indication that this is a full quarterly report with comprehensive financial statements, but rather a presentation summarizing financial performance and business strategy for the quarter. Therefore, this document fits the definition of an Investor Presentation (IP).
2025-08-06 English
Please find attached the Investor Presentation Q1 FY 26
Investor Presentation Classification · 95% confidence The document is titled 'Investor Presentation – Q1’ FY26' and is addressed to stock exchanges, indicating it is a formal communication to investors. The content includes detailed business and financial highlights for the quarter ended June 30, 2025, such as sales figures, market leadership, and segment performance. The document is approximately 15,000 characters long, which is consistent with a detailed presentation rather than a brief announcement. The text explicitly states it is an 'Investor Presentation' and contains forward-looking statements, business overview, and financial data typical of investor presentations. There is no indication that this is a full quarterly report (IR) with comprehensive financial statements, nor is it a simple announcement of a report publication (RPA). Therefore, the document fits the category of an Investor Presentation (IP).
2025-08-06 English
Please find attached file
Regulatory Filings
2025-08-06 English
Please find attached file
Regulatory Filings
2025-08-06 English
Appointment of M/s PD & Associates as Secretarial Auditor of the Company
Regulatory Filings
2025-08-06 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.